2076975 2077203
최종편집 2024-05-27 07:58 (월)
10 listed pharmaceutical companies’ asset turnover in the first half exceeds 0.5
상태바
10 listed pharmaceutical companies’ asset turnover in the first half exceeds 0.5
  • Hyeokgi Lee, Newsmp
  • 승인 2022.08.30 20:47
  • 댓글 0
이 기사를 공유합니다

An average of 0.37 for 62 companies… Jeil Pharmaceutical leads with 0.78

[Newsmp] In the first half, 10 listed pharmaceutical companies achieved sales of more than half of their assets.

Newsmp tallied the asset turnover of 62 Korean pharmaceutical companies in the first half and the average asset turnover was 0.37.

The asset turnover of 10 companies exceeded 0.5, and Jeil Pharmaceutical’s asset turnover reached 0.87 in the first half. This means that sales in the first half amounted to 87% of the total assets.

Kwang Dong Pharmaceutical also achieved sales of nearly 80% of its total assets with an asset turnover of 0.76, followed by Chong Kun Dang Pharmaceutical with 0.66, Korea Arlico Pharm with 0.63, and DongKoo Bio & Pharma with 0.60.

JW shinyak recorded 0.54, Daewon Pharmaceutical and Huons 0.53, and Youngjin Pharmaceutical 0.52, showing a trend of annual sales exceeding the total assets.

In addition, Kukje Pharma followed with 0.46, Ahn-Gook Pharmaceutical, DongKook Pharmaceutical, and Ildong Pharmaceutical with 0.45, Korean Drug, Daewoong Pharmaceutical, Dongsung Pharmaceutical, and Boryung Pharmaceutical with 0.43, Cho-A Pharmaceutical with 0.41, and Seoul Pharma with 0.40.

Asset turnover of JW Life Science, Kyongbo Pharmaceutical, Dongwha Pharm, SinSin Pharmaceutical, and Samjin Pharmaceutical exceeded the average of 64 companies.

More than a third of the 62 companies, including Samil Pharmaceutical, Yuhan Corporation, Yuyu Pharma, Jin Yang Pharmaceutical, Il-Yang Pharmaceutical, Hwail Pharmaceutical, Myungmoon Pharmaceutical, GC Pharma, DAE HWA Pharmaceutical, Hanmi Pharmaceutical, Korea United Pharmaceutical, Hana Pharm, Daihan Pharmaceutical, Celltrion Pharm, Handok, Kyung Dong Pharmaceutical, and Korea Pharmacy, were between 0.3 and 0.4.

Moreover, Sinil Pharmaceutical, CKD Bio, PharmGen Science, Dong-A ST, Whanin Pharmaceutical, Withus Pharmaceutical, HanAll Biopharma, Union Korea Pharmaceutical, and SamChunDang Pharm exceeded 0.25, recording more than 0.5 asset turnover per year, while Shinpoong Pharmaceutical, HK inno.N, Kyung Nam Pharm, and Bukwang Pharmaceutical were above 0.2.

CMG Pharmaceutical, Sam-A Pharmaceutical, ST Pharm, Samsung Pharmaceutical, and Reyon Pharmaceutical showed 0.1 to 0.2, and Ilsung Pharmaceutical and Aprogen Pharmaceuticals indicated aster turnover of less than 0.1.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.